Trials / Completed
CompletedNCT01693848
"Cancersensor" Metastasis Resection
Molecularly Imprinted Polymer Sensors of Modified Nucleosides for Non-invasive Monitoring, of Cancer Therapy: Impact of Surgical Resection of Metastasis on Urinary Excretion of Modified Nucleosides.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (actual)
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Observational, non randomized study aimed at measuring the effect of surgical resection of metastasis in the urinary concentrations of physiological modified nucleosides in 45 patients with metastatic colorectal cancer.
Conditions
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2012-09-26
- Last updated
- 2016-12-07
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01693848. Inclusion in this directory is not an endorsement.